ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1

Historical Holders from Q4 2015 to Q4 2021

Type / Class
Debt / NOTE 1.000%11/1
All holders as of 31 Dec 2021
Q4 2021
Total 13F principal, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1

Period Principal Value Change Price Investors
2021 Q4 0 $0 -$49,938,000 0
2021 Q3 49,835,500 $49,938,000 +$366,667 $1 18
2021 Q2 49,494,500 $49,785,000 -$245,029,570 $1 22
2021 Q1 291,876,400 $299,156,298 +$81,055,775 $1.02 41
2020 Q4 214,660,400 $235,351,756 +$9,737,108 $1.08 41
2020 Q3 210,410,600 $220,039,953 +$1,735,345 $1.03 43
2020 Q2 207,823,100 $231,621,765 +$884,434 $1.1 48
2020 Q1 207,530,234 $210,897,141 +$12,815,532 $1.01 49
2019 Q4 194,112,610 $223,004,087 -$464,181,582 $1.14 52
2019 Q3 603,301,410 $689,201,293 +$48,576,904 $1.14 59
2019 Q2 559,810,772 $663,662,866 -$31,257,430 $1.18 59
2019 Q1 568,921,910 $769,134,948 +$30,791,119 $1.35 58
2018 Q4 552,325,972 $592,038,514 +$18,413,075 $1.07 49
2018 Q3 516,120,400 $544,422,589 -$7,103,121 $1.05 44
2018 Q2 523,679,400 $514,053,375 -$31,956,544 $0.9823 46
2018 Q1 555,020,400 $550,590,387 -$25,155,394 $0.9904 53
2017 Q4 581,359,400 $615,025,630 -$10,883,086 $1.06 50
2017 Q3 591,689,000 $627,229,697 +$26,831,916 $1.06 42
2017 Q2 565,996,310 $601,902,851 -$21,072,647 $1.06 44
2017 Q1 587,366,011 $566,481,242 +$8,318,121 $0.9645 44
2016 Q4 577,411,009 $587,717,522 +$209,944,883 $1.02 44
2016 Q3 371,321,000 $346,421,691 -$59,401,536 $0.9329 39
2016 Q2 458,620,000 $325,189,980 -$5,571,506 $0.7086 44
2016 Q1 461,458,000 $421,344,894 +$26,191,596 $0.9113 39
2015 Q4 437,645,000 $491,457,000 +$448,400,000 $1.13 40